Sara Bernal
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 10, 2026
Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 19, 2026
Integrating preconception carrier screening into public health: lessons learned from a pilot implementation study.
Journal: Journal of assisted reproduction and genetics
Published: December 27, 2025
Navigating Schizophrenia Treatment: Challenges in Pharmacogenetic Counseling.
Journal: Spanish journal of psychiatry and mental health
Published: July 29, 2025
Navigating schizophrenia treatment: Challenges in pharmacogenetic counseling.
Journal: Spanish journal of psychiatry and mental health
Published: July 29, 2025
Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign.
Journal: Journal of neurology
Published: July 21, 2025
A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration.
Journal: Annals of clinical and translational neurology
Published: December 17, 2024
Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 18, 2024
Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum.
Journal: Brain : a journal of neurology
Published: October 06, 2023
Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: September 15, 2023
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen.
Journal: Journal of neuromuscular diseases
Published: April 11, 2023
Last Updated: 09/26/2026